We intend to develop MeconCash into a platform that allows user’s assets to be transferred and traded between different types of services by integrating point reward systems, contents purchase, and settlement, which are currently operated separately between existing services and those under development. To that end, we will build the reward and settlement system, develop the API to connect it with other services, and build an ecosystem that can be used in the on- and off-line real economy. All this will ensure the usability, connectivity, and sustainability of MeconCash. We will develop a variety of mobile-based applications, games, and contents on the platform and link it with such services as online marketplaces where users can purchase products. The reward system used by a service generally invalidates the rewards owned by users when the service is terminated. MeconCash, however, can transform the rewards obtained from using our services into valuable assets. As such, users will be able to fulfill the demand for new services with MeconCash even when the services they use are terminated, make transactions between them, and use the assets in the real economy. We will stabilize the MeconCash ecosystem by developing new blockchain-based businesses and linking it with external services which already exists. Additionally, MeconCash will be available in 70% of ATMs in Korea so that users can directly withdraw MeconCash to fiat money.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.

Winstars is a decentralized gaming platform with a catalog of gambling resources, the core is built on Blockchain and smart contracts. We rely on simple and attractive games designed for anyone, not even a gambler, with transparent and guaranteed honest results. The goal of the project is to create an international, absolutely transparent gambling operator built on the basis of Ethereum, with the ability to check the history of each bet and game, with attractive affiliate program and the best opportunities to earn on the gambling market.

By accepting to share their shopping data with the network, a shopper earns reward tokens, while the data is used by retailers to build redemption offers that best suit each customer’s needs. Shoppers can redeem their tokens through these exclusive and personalized offers.

Lohn is a widely spread contractual form in various industrial fields of international cooperation relations, especially in the industry of clothing, footwear, leather, furniture, software and hardware, pharmaceutical, metal working, metallurgical, machine tools, automotive, automation, machine building industry, electronics and appliance industry, food and beverage industry, petrochemical industry. The lohn (processing economy) has been and will be a solution to produce goods at reasonable and high-quality prices through the efficient use of labor and cheap raw materials in emerging economies. It is also a business model that creates economic and social progress across the world bringing together markets with productive resources and capabilities. The trading platform developed by the lohncontrol project will create global opportunities for small and medium-sized businesses that are responsible for generating 60% of GDP. It will give them a visibility that they do not have at this time and will encourage the development of direct business between them. This means low manufacturing costs and greater adaptation to market demands. Those who will win at the end of this interaction will be consumers who will get good products at realistic prices.